Join
Live feed
·
INSIDERFilingvia Quantisnow
Jade Biosciences Inc. logo

Chief Executive Officer Frohlich Tom bought $44,400 worth of shares (6,000 units at $7.40) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
JBIO· Jade Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track JBIO (Jade Biosciences Inc.) and more on Quantisnow.